Introduction

This week, biocon announced the acquisition of biosimilar assets american pharmasutical company beatrice. Biocon's shares fell nearly 12 % on the n s c right after the announcement. We have with us biocon biologics as deputy syou sheha tambe and ete skiran somanshe along with eti primes vica tandakr to take us through the contours of the deal,. what went wrong and how biocon can recover from its share price set back.